Formidable Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Buy
56,869
+5,792
+11% +$152K 0.25% 80
2026
Q1
$1.27M Buy
51,077
+4,632
+10% +$123K 0.2% 98
2025
Q4
$1.18M Sell
46,445
-4,329
-9% -$109K 0.17% 112
2025
Q3
$1.23M Sell
50,774
-4,291
-8% -$106K 0.19% 101
2025
Q2
$1.4M Hold
55,065
0.23% 80
2025
Q1
$1.4M Sell
55,065
-3,525
-6% -$92.2K 0.23% 80
2024
Q4
$1.55M Sell
58,590
-507
-0.9% -$13.8K 0.26% 76
2024
Q3
$1.71M Sell
59,097
-233
-0.4% -$6.8K 0.27% 74
2024
Q2
$1.66M Sell
59,330
-3,678
-6% -$101K 0.27% 74
2024
Q1
$1.75M Sell
63,008
-1,600
-2% -$44.4K 0.29% 72
2023
Q4
$1.86M Sell
64,608
-5,154
-7% -$156K 0.39% 46
2023
Q3
$2.31M Buy
69,762
+1,871
+3% +$66.2K 0.51% 31
2023
Q2
$2.49M Buy
67,891
+23,363
+52% +$909K 0.54% 26
2023
Q1
$1.84M Buy
44,528
+17
+0% +$734 0.39% 40
2022
Q4
$2.28M Sell
44,511
-387
-0.9% -$18.6K 0.52% 28
2022
Q3
$2.05M Buy
44,898
+114
+0.3% +$5.54K 0.48% 33
2022
Q2
$2.34M Buy
44,784
+120
+0.3% +$6.12K 0.53% 28
2022
Q1
$2.31M Sell
44,664
-1,046
-2% -$54.3K 0.44% 39
2021
Q4
$2.51M Sell
45,710
-238
-0.5% -$11.8K 0.48% 34
2021
Q3
$1.98M Sell
45,948
-395
-0.9% -$17.5K 0.37% 46
2021
Q2
$1.87M Sell
46,343
-3,268
-7% -$127K 0.4% 44
2021
Q1
$1.8M Sell
49,611
-580
-1% -$20.6K 0.39% 52
2020
Q4
$1.85M Sell
50,191
-1,536
-3% -$56.3K 0.43% 43
2020
Q3
$1.79M Buy
51,727
+645
+1% +$22.6K 0.52% 35
2020
Q2
$1.72M Buy
51,082
+4,226
+9% +$144K 0.51% 43
2020
Q1
$1.45M Buy
46,856
+3,547
+8% +$121K 0.57% 36
2019
Q4
$1.66M Buy
+43,309
New +$1.54M 0.52% 44
2019
Q3
Sell
-45,269
Closed -$1.68M 202
2019
Q2
$1.68M Buy
+45,269
New +$1.8M 0.58% 36
2019
Q1
Sell
-47,461
Closed -$1.97M 234
2018
Q4
$1.97M Buy
47,461
+727
+2% +$30.2K 1.04% 19
2018
Q3
$1.99M Sell
46,734
-1,989
-4% -$76.6K 0.78% 24
2018
Q2
$1.68M Buy
48,723
+328
+0.7% +$11.2K 0.72% 30
2018
Q1
$1.63M Sell
48,395
-346
-0.7% -$11.9K 0.82% 23
2017
Q4
$1.68M Sell
48,741
-437
-0.9% -$14.9K 0.77% 27
2017
Q3
$1.67M Buy
49,178
+482
+1% +$15.5K 0.7% 22
2017
Q2
$1.55M Buy
48,696
+416
+0.9% +$13.1K 0.77% 20
2017
Q1
$1.53M Sell
48,280
-1,220
-2% -$38.5K 0.67% 23
2016
Q4
$1.52M Sell
49,500
-962
-2% -$29.4K 0.77% 23
2016
Q3
$1.62M Buy
50,462
+724
+1% +$24.2K 0.81% 20
2016
Q2
$1.73M Buy
49,738
+4,301
+9% +$137K 0.96% 19
2016
Q1
$1.43M Sell
45,437
-41
-0.1% -$1.17K 1.01% 18
2015
Q4
$1.36M Sell
45,478
-63
-0.1% -$1.98K 0.94% 20
2015
Q3
$1.36M Buy
45,541
+1,467
+3% +$47K 0.91% 20
2015
Q2
$1.4M Buy
44,074
+617
+1% +$20.1K 0.89% 21
2015
Q1
$1.39M Buy
43,457
+2,487
+6% +$79.1K 0.92% 22
2014
Q4
$1.21M Buy
40,970
+1,590
+4% +$45.6K 0.83% 24
2014
Q3
$1.13M Buy
39,380
+9,583
+32% +$269K 0.75% 29
2014
Q2
$839K Buy
29,797
+11
+0% +$314 0.51% 41
2014
Q1
$905K Buy
29,786
+9
+0% +$268 0.63% 29
2013
Q4
$882K Sell
29,777
-603
-2% -$17.6K 0.59% 31
2013
Q3
$836K Buy
+30,380
New +$827K 0.72% 32

Other funds holding PFE

Formidable Asset Management's PFE Position: Q2 2026 in Review

Formidable Asset Management increased its Pfizer (PFE) stake by 11% in Q2 2026, buying an estimated $152K and bringing the position to 56,869 shares worth $1.6M. The position accounts for 0.25% of the portfolio, ranked #80.

Formidable Asset Management first reported a position in PFE in Q3 2013 and has held it in 50 quarters since. The position peaked at $2.51M in Q4 2021. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Formidable Asset Management held 56,869 shares of Pfizer worth $1.6M as of Q2 2026.
  • Formidable Asset Management bought 5,792 Pfizer shares in Q2 2026, an estimated $152K.
  • Pfizer made up 0.25% of Formidable Asset Management's portfolio in Q2 2026, its #80 holding.
  • Formidable Asset Management first reported a position in Pfizer in Q3 2013 and has held it in 50 quarters since.
  • Formidable Asset Management's Pfizer position peaked at $2.51M in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.